An Exploratory Study of CS-3150 to Evaluate the Relation between Antihypertensive Effect and Baseline Factors Compared to Olmesartan Medoxomil in Patients with Essential Hypertension

Trial Profile

An Exploratory Study of CS-3150 to Evaluate the Relation between Antihypertensive Effect and Baseline Factors Compared to Olmesartan Medoxomil in Patients with Essential Hypertension

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Aug 2017

At a glance

  • Drugs Esaxerenone (Primary) ; Olmesartan medoxomil
  • Indications Essential hypertension
  • Focus Registrational; Therapeutic Use
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 15 May 2017 Status changed from active, no longer recruiting to completed.
    • 14 Feb 2017 Planned End Date changed from 1 Dec 2017 to 31 Dec 2017.
    • 14 Feb 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top